论文信息 - Phase II Study of Selumetinib in Children and Young Adults With Tumors Harboring Activating Mitogen-Activated Protein Kinase Pathway Genetic Alterations: Arm E of the NCI-COG Pediatric MATCH Trial - 字舞流文

Phase II Study of Selumetinib in Children and Young Adults With Tumors Harboring Activating Mitogen-Activated Protein Kinase Pathway Genetic Alterations: Arm E of the NCI-COG Pediatric MATCH Trial

N. Ramirez | T. Alonzo | M. Mooney | P. M. Williams | D. Hawkins | J. Reid | S. Roy-Chowdhuri | K. Janeway | N. Takebe | C. Allen | N. Seibel | A. Jaju | S. Berg | J. V. Tricoli | E. Fox | J. Mhlanga | O. Eckstein | D. Patton | Brent Coffey | Lauren Saguilig | J. Piao | D. W. Parsons | P. Williams | Brent D. Coffey